Based on the available information, this event is deemed to be a reportable malfunction.No additional patient/event details have been provided to date.Should additional information become available a follow-up report will be submitted.Reported to the fda on july 14, 2016.(b)(4).
|
A batch record review was completed for lot # 5l02402 and sights no discrepancies, deviations or non-conformances.The crew requirements and responsibilities, process parameters, quality and in-process inspections, line operations, process troubleshooting and relevant documents to the process were run according to the process instructions.The process requirements results were documented in the product batch records and the product was packaged and labeled under the packaging and labeling specification.No physical sample or photograph is expected.This issue will be monitored through the post market product monitoring review process.No additional patient/event details have been provided to date.Should additional information become available a follow-up report will be submitted.Reported to the fda on october 11, 2016.
|